Developing New Medicines
Our medicines save and transform the lives of millions in the UK and around the world every year, but developing them is a long and complicated process.
Did you know, on average, it can take around 12 years and more than £1bn to develop each new medicine?1 Moreover, for every 10-20 medicines identified in the laboratory, only one will ever reach patients - the others will fail along the way.2
We passionately believe that medicine development shouldn't be done alone - collaboration is essential. That's why we work with other innovators across the health landscape including academic scientists, patient organisations, governments, other bio-pharmaceutical companies and healthcare professionals, in the hope to discover 'Breakthroughs that change patients lives'.
Read more about the journey from 'Molecule to Medicine' below:
- National Center for Biotechnology Information. Changing R&D models in research-based pharmaceutical companies April 2016.
- ASCPT. Approval success rates of drug candidates based on target, action, modality, application, and their combinations April 2021.
- Pfizer data on file. March 2021.
- NHS UK. Clinical Trials May 2019.